title: Ratiometry of transmembrane voltage-sensitive fluorescent dye emission in hearts.
abstract: Transmembrane voltage-sensitive fluorescence measurements are limited by baseline drift that can obscure changes in resting membrane potential and by motion artifacts that can obscure repolarization. Voltage-dependent shift of emission wavelengths may allow reduction of drift and motion artifacts by emission ratiometry. We have tested this for action potentials and potassium-induced changes in resting membrane potential in rabbit hearts stained with di-4-ANEPPS [Pyridinium, 4-(2-(6-(dibutylamino)-2-naphthalenyl) ethenyl)-1-(3-sulfopropyl)-, hydroxide, inner salt] using laser excitation (488 nm) and a two-photomultiplier tube system or spectrofluorometer (resolution of 500-1,000 Hz and <1 mm). Green and red emissions produced upright and inverted action potentials, respectively. Ratios of green emission to red emission followed action potential contours and exhibited larger fractional changes than either emission alone (P < 0.001). The largest changes and signal-to-noise ratio (signal/noise) were obtained with numerator wavelengths of 525-550 nm and denominator wavelengths of 650-700 nm. Ratiometry lessened drift 56-66% (P < 0.015) and indicated decreases in resting membrane potential. Ratiometry lessened motion artifacts and increased magnitudes of deflections representing phase-zero depolarizations relative to total deflections by 123-188% in intact hearts (P < 0.02). Durations of action potentials at different pacing rates, temperatures, and potassium concentrations were independent of whether they were measured ratiometrically or with microelectrodes (P > or = 0.65). The ratiometric calibration slope was 0.017/100 mV and decreased with time. Thus emission ratiometry lessens the effects of motion and drift and indicates resting membrane potential changes and repolarization.
authors.affiliation: Department of Biomedical Engineering of the School of Engineering, The University of Alabama at Birmingham, Alabama 35294-0019, USA. sbk@crml.uab.edu
authors.forename: S B
authors.initials: SB
authors.lastname: Knisley
authors.forename: R K
authors.initials: RK
authors.lastname: Justice
authors.forename: W
authors.initials: W
authors.lastname: Kong
authors.forename: P L
authors.initials: PL
authors.lastname: Johnson
mesh_terms: D000818:Animals; D016477:Artifacts; D018780:Body Surface Potential Mapping; D002304:Cardiac Pacing, Artificial; D005069:Evaluation Studies as Topic; D005456:Fluorescent Dyes; D066298:In Vitro Techniques; D007834:Lasers; D008564:Membrane Potentials / Q000187:drug effects / Q000502:physiology*; D008839:Microelectrodes; D009206:Myocardium / Q000378:metabolism*; D011188:Potassium / Q000378:metabolism / Q000494:pharmacology; D011199:Potentiometry / Q000379:methods; D011726:Pyridinium Compounds; D011817:Rabbits; D013050:Spectrometry, Fluorescence / Q000295:instrumentation / Q000379:methods*; D013696:Temperature
chemical_list: D005456:Fluorescent Dyes; D011726:Pyridinium Compounds; C050019:1-(3-sulfonatopropyl)-4-(beta)(2-(di-n-butylamino)-6-naphthylvinyl)pyridinium betaine; D011188:Potassium